Cargando…
Frequent neurocognitive deficits after recovery from mild COVID-19
Neuropsychiatric complications associated with coronavirus disease 2019 caused by the Coronavirus SARS-CoV-2 (COVID-19) are increasingly appreciated. While most studies have focussed on severely affected individuals during acute infection, it remains unclear whether mild COVID-19 results in neurocog...
Autores principales: | Woo, Marcel S, Malsy, Jakob, Pöttgen, Jana, Seddiq Zai, Susan, Ufer, Friederike, Hadjilaou, Alexandros, Schmiedel, Stefan, Addo, Marylyn M, Gerloff, Christian, Heesen, Christoph, Schulze Zur Wiesch, Julian, Friese, Manuel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717144/ https://www.ncbi.nlm.nih.gov/pubmed/33376990 http://dx.doi.org/10.1093/braincomms/fcaa205 |
Ejemplares similares
-
Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness
por: Jochum, Johannes, et al.
Publicado: (2021) -
Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic review
por: Seddiq Zai, Susan, et al.
Publicado: (2022) -
aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021) -
Respiratory muscle dysfunction in long-COVID patients
por: Hennigs, Jan K., et al.
Publicado: (2022) -
Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections
por: Woo, Marcel S, et al.
Publicado: (2023)